The pharmacokinetic profile of the combination of naproxen and tizanidine in rat

Selene Isabel Patiño-Camacho, María Guadalupe Lozoya Moreno, Francisco Javier Flores-Murrieta, Myrna Déciga-Campos

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Preclinical Research Naproxen is an anti-inflammatory drug used in a variety of anti-inflammatory syndromes. There is evidence showing that tizanidine enhances the anti-inflammatory effect in rats. This study examines the pharmacokinetics of naproxen when it is combined with tizanidine. Combining these two drugs is an attractive modality for inflammation complaints. Oral coadministration of naproxen/tizanidine produced a synergistic anti-inflammatory effect in rats. The swelling of the rat paw was measured by a plethysmometer using carrageenan as an inflammatory agent. In this study, rats received oral doses of naproxen (1, 3, and 4.2 mg/kg), and these doses were combined with a fixed dose of tizanidine (0.01 mg/kg). To evaluate the pharmacokinetic interaction between naproxen/tizanidine, blood samples were obtained at selected times in the 24 h after oral administration and were analyzed using a validated high-performance liquid chromatography method. Systemic administration of naproxen alone or in combination with tizanidine produced a dose-dependent anti-inflammatory effect. In the pharmacokinetic interaction study, no statistically significant difference was observed for the naproxen concentration-time profiles in the presence of tizanidine. The experimental findings suggest that systemic tizanidine is able to increase the naproxen-induced anti-inflammatory effect in rats. This effect was not due to a modification of the bioavailability of naproxen. © 2013 Wiley Periodicals, Inc.
Original languageAmerican English
Pages (from-to)31-37
Number of pages7
JournalDrug Development Research
DOIs
StatePublished - 1 Feb 2013

Fingerprint

Naproxen
Pharmacokinetics
Anti-Inflammatory Agents
tizanidine
Carrageenan
Pharmaceutical Preparations
Biological Availability
Oral Administration
High Pressure Liquid Chromatography
Inflammation

Cite this

@article{d32fafdcf74d4b2c99c30f50df71e952,
title = "The pharmacokinetic profile of the combination of naproxen and tizanidine in rat",
abstract = "Preclinical Research Naproxen is an anti-inflammatory drug used in a variety of anti-inflammatory syndromes. There is evidence showing that tizanidine enhances the anti-inflammatory effect in rats. This study examines the pharmacokinetics of naproxen when it is combined with tizanidine. Combining these two drugs is an attractive modality for inflammation complaints. Oral coadministration of naproxen/tizanidine produced a synergistic anti-inflammatory effect in rats. The swelling of the rat paw was measured by a plethysmometer using carrageenan as an inflammatory agent. In this study, rats received oral doses of naproxen (1, 3, and 4.2 mg/kg), and these doses were combined with a fixed dose of tizanidine (0.01 mg/kg). To evaluate the pharmacokinetic interaction between naproxen/tizanidine, blood samples were obtained at selected times in the 24 h after oral administration and were analyzed using a validated high-performance liquid chromatography method. Systemic administration of naproxen alone or in combination with tizanidine produced a dose-dependent anti-inflammatory effect. In the pharmacokinetic interaction study, no statistically significant difference was observed for the naproxen concentration-time profiles in the presence of tizanidine. The experimental findings suggest that systemic tizanidine is able to increase the naproxen-induced anti-inflammatory effect in rats. This effect was not due to a modification of the bioavailability of naproxen. {\circledC} 2013 Wiley Periodicals, Inc.",
author = "Pati{\~n}o-Camacho, {Selene Isabel} and Moreno, {Mar{\'i}a Guadalupe Lozoya} and Flores-Murrieta, {Francisco Javier} and Myrna D{\'e}ciga-Campos",
year = "2013",
month = "2",
day = "1",
doi = "10.1002/ddr.21053",
language = "American English",
pages = "31--37",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",

}

The pharmacokinetic profile of the combination of naproxen and tizanidine in rat. / Patiño-Camacho, Selene Isabel; Moreno, María Guadalupe Lozoya; Flores-Murrieta, Francisco Javier; Déciga-Campos, Myrna.

In: Drug Development Research, 01.02.2013, p. 31-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The pharmacokinetic profile of the combination of naproxen and tizanidine in rat

AU - Patiño-Camacho, Selene Isabel

AU - Moreno, María Guadalupe Lozoya

AU - Flores-Murrieta, Francisco Javier

AU - Déciga-Campos, Myrna

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Preclinical Research Naproxen is an anti-inflammatory drug used in a variety of anti-inflammatory syndromes. There is evidence showing that tizanidine enhances the anti-inflammatory effect in rats. This study examines the pharmacokinetics of naproxen when it is combined with tizanidine. Combining these two drugs is an attractive modality for inflammation complaints. Oral coadministration of naproxen/tizanidine produced a synergistic anti-inflammatory effect in rats. The swelling of the rat paw was measured by a plethysmometer using carrageenan as an inflammatory agent. In this study, rats received oral doses of naproxen (1, 3, and 4.2 mg/kg), and these doses were combined with a fixed dose of tizanidine (0.01 mg/kg). To evaluate the pharmacokinetic interaction between naproxen/tizanidine, blood samples were obtained at selected times in the 24 h after oral administration and were analyzed using a validated high-performance liquid chromatography method. Systemic administration of naproxen alone or in combination with tizanidine produced a dose-dependent anti-inflammatory effect. In the pharmacokinetic interaction study, no statistically significant difference was observed for the naproxen concentration-time profiles in the presence of tizanidine. The experimental findings suggest that systemic tizanidine is able to increase the naproxen-induced anti-inflammatory effect in rats. This effect was not due to a modification of the bioavailability of naproxen. © 2013 Wiley Periodicals, Inc.

AB - Preclinical Research Naproxen is an anti-inflammatory drug used in a variety of anti-inflammatory syndromes. There is evidence showing that tizanidine enhances the anti-inflammatory effect in rats. This study examines the pharmacokinetics of naproxen when it is combined with tizanidine. Combining these two drugs is an attractive modality for inflammation complaints. Oral coadministration of naproxen/tizanidine produced a synergistic anti-inflammatory effect in rats. The swelling of the rat paw was measured by a plethysmometer using carrageenan as an inflammatory agent. In this study, rats received oral doses of naproxen (1, 3, and 4.2 mg/kg), and these doses were combined with a fixed dose of tizanidine (0.01 mg/kg). To evaluate the pharmacokinetic interaction between naproxen/tizanidine, blood samples were obtained at selected times in the 24 h after oral administration and were analyzed using a validated high-performance liquid chromatography method. Systemic administration of naproxen alone or in combination with tizanidine produced a dose-dependent anti-inflammatory effect. In the pharmacokinetic interaction study, no statistically significant difference was observed for the naproxen concentration-time profiles in the presence of tizanidine. The experimental findings suggest that systemic tizanidine is able to increase the naproxen-induced anti-inflammatory effect in rats. This effect was not due to a modification of the bioavailability of naproxen. © 2013 Wiley Periodicals, Inc.

U2 - 10.1002/ddr.21053

DO - 10.1002/ddr.21053

M3 - Article

SP - 31

EP - 37

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

ER -